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Identification of the Earliest B Lineage Stage
in Mouse Bone Marrow
Yue-Sheng Li,* Robert Wasserman,† very low levels of mRNA from recombinase-activating
genes (Rag-1 and Rag-2), and very little immunoglobulinKyoko Hayakawa,* and Richard R. Hardy*
heavy chain D–J rearrangement (Hardy et al., 1991; Eh-*Institute for Cancer Research
lich et al., 1993; Li et al., 1993). In addition, some cellsFox Chase Cancer Center
in this population could proliferate on a stromal cell layerPhiladelphia, Pennsylvania 19111
and give rise to more mature B lineage subsets (Hardy†Division of Oncology
et al., 1991). However, this cell fraction was consideredThe Children’s Hospital of Philadelphia
potentially heterogeneous, since it was defined largelyand Department of Pediatrics
by the lack of surface markers (B2201CD431 butThe University of Pennsylvania School of Medicine
HSA2BP-12). To discriminate progenitor cells commit-Philadelphia, Pennsylvania 19104
ted specifically to the B lineage from progenitors that
were multipotential or committed to other lineages, we
analyzed bone marrow cells for the expression of theSummary
surface markers B220 and HSA along with twoadditional
surface markers, AA4.1 and CD4. AA4.1 is expressedWe have identified a very early stage of B lineage cells
on HSC (McKearn et al., 1985), B cell/myeloid bipotentialin the CD45R (B220)1CD24 (HSA)2 pre-pro-B fraction
progenitors (Cumano et al., 1992), and early B lineageof mouse bone marrow delineated by expression of
cells (McKearn et al., 1985; Loken et al., 1988). CD4,AA4.1, a molecule found on stem cells and early B
although more commonly considered as a marker oflineage cells. These cells are B lineage precursors
the T lineage, is expressed at low levels on lymphoidbased on their capacity to generate B lineage cells
progenitors (Fredrickson and Basch, 1989; Wu et al.,rapidly in stromal-dependent culture and their expres-
1991a, 1991b; Chervenak et al., 1993). We used tran-sion of high levels of germline IgH transcripts in the
scription from the germline IgH locus, m0 (Alessandriniabsence of Rag-1/2. Half of these AA4.11 precursors
and Desiderio, 1991; Schlissel et al., 1991b), as evidenceexpress low levels of CD4, characteristic of lymphoid
for B lineage commitment and also investigated the lev-progenitors, but few if any have up-regulated CD19, a
els of Rag-1 and Rag-2 (Schatz et al., 1989; Oettingermolecule expressed very early in the B lineage. Fur-
et al., 1990) mRNA, since transcription of these recombi-thermore, expression of genes encoding pre-B and
nase genes should initiate before or coincident with IgHB cell receptor components (mb-1, B29, and l5) and
rearrangement (Alt et al., 1987; Schatz et al., 1992; Li ettranscription factors necessary for B lineage differen-
al., 1993).
tiation (BSAP, E12, E47, and Id) provide further support
Our analysis shows that about half of the B2201CD431
for designating these cells as the earliest B cell pre-
HSA2 cells (previously termed Fr. A; Hardy et al., 1991)cursors.
express AA4.1 and that only the AA4.11 subfraction can
proliferate on a stromal cell monolayer, suggesting that
Introduction only this subfraction includes B lineage precursors. Fur-
thermore, the expression of a m transgene by most cells
In mice, hematopoietic stem cells (HSC) become com- in this subfraction suggests that it is a relatively homoge-
mitted to the B lineage in the liver of the fetus and in nous population. These cells have high levels of m0 tran-
the bone marrow of adult animals (Osmond, 1990; Rolink scripts but very low levels of Rag-1 and Rag-2 express
and Melchers, 1993). HSC are defined by their capacity ion compared with the more differentiated B2201CD431
to repopulate multiple hematopoietic lineages for ex- HSA1 pro-B cells, consistent with the idea that locus
tended periods and express a characteristic pattern of accessibility precedes functional recombinase activity.
cell surfacemolecules (Ikuta et al.,1992). More restricted Quantitating expression of CD4 allows a further refine-
progenitors, such as common lymphoid precursors (Wu ment of this analysis, since only primitive multilineage
et al., 1991a) and bipotential B/myeloid progenitors (Cu- hematopoietic precursors bear low levels of this mole-
mano et al., 1992) have also been described. We have cule and its expression should be extinguished during
shown previously that pro-B cells, characterized by ex- the earliest stages of B lineage development. Thus,
tensive D–J, but not V–D–J, rearrangements (Hardy et among CD431HSA2AA4.11 cells, we describe three cell
al., 1991) will generate B cell–restricted progeny upon fractions, termed A0, A1, and A2, that can be identified
transfer intoSCID mice (Hardyand Hayakawa,1991).How- by the surface expression patterns B2202CD41, B2201
ever, the identification of precursor cellsduring or imme- CD41, and B2201CD42, respectively. The A0 fraction
diately after commitment to the B lineage has remained resembles the common lymphoid progenitor population
elusive. This is partly due to the difficulty of defining reported by others (Wu et al., 1991a, 1991b; Chervenak
such populations, since they will likely be rare and lack et al., 1993), whereas A1 and A2 represent the earliest
immunoglobulin H (IgH) rearrangements, a clear indica- identifiable populations of B lineage cells. The pattern
tor of B lineage commitment in later-stage cells. of expression of a set of B lineage–restricted genes and
Previously, we have identified stages of early B lin- of a series of transcription factors that regulate B lineage
eage development in mouse bone marrow using two development validate the B lineage character of these
different combinations of four cell surface markers fractions and provide further evidence to support this
ordering.(Hardy et al., 1991). The earliest stage (Fr. A) possessed
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Figure 1. Expression of AA4.1 Delineates an Early Stage of B2201CD431HSA2 B Lineage Cells
(A) Flow cytometry of bone marrow showing separation of early B lineage subsets in normal BALB/c mice. Bone marrow cells were stained
simultaneously with FL-anti-CD43, APC-anti-B220, BI-anti-HSA (revealed by TR–avidin), and either PE-anti-BP-1 or PE-anti-AA4.1. In the first
panel, B220 (CD45R)1CD431 cells were resolved into three pro-B cell subsets (Fr. A–C) and one transitional early pre-B cell subset (Fr. C9)
based on the expression of HSA and BP-1. Each fraction represents approximately 1.0%–1.5% of total bone marrow cells. In the second
panel, AA4.1 expression on bone marrow B2201CD431HSA2 cells is used to discriminate two subsets, each 0.5%–0.7% of total bone marrow
cells.
(B) Proliferation of AA4.11 cells from the B2201CD431HSA2 fraction in stromalcell cultures. AA4.11 and AA4.12 cells from the B2201CD431HSA2
fraction (104 cells per well) were sorted directly onto preestablished stromal layers (FLST2) in 1 ml multiwell plates. After 7 days, cells were
harvested, stained for B220, HSA, and IgM expression, and counted by flow cytometry. Representative data from three experiments are
shown.
(C) Differential expression of a heavy chain transgene in AA4.11 and AA4.12 cells from Rag-12 mice bearing a human m transgene.
B2201CD431HSA2 cells were fractionated by cell sorter and then permeabilized, fixed, stained with anti-m, and analyzed by flow cytometry.
Representative data from two experiments are shown. In these analyses, <5% of AA4.12 cells and >90% of AA4.11 were m–Tg1. Background
fluoresence levels (stippled histograms) were determined by staining cells with an irrelevant antibody.
Results surface molecule, AA4.1, found on stem cells and early
B lineage cells (McKearn et al., 1985; Loken et al., 1988;
Cumano et al., 1992) to subdivide Fr. A further. ThisResolution of Pre-Pro-B Subsets in Bone
Marrow Using AA4.1 analysis revealed that only about half of these cells ex-
pressed AA4.1 (Figure 1A). We compared the ability ofWe previously used flow cytometry with two four-color
combinations of fluorescent labeled monoclonal anti- Fr. A cells that lacked or expressed AA4.1 to grow in
vitro on a stromal cell layer, a property of early B lineagebodies to fractionate B lineage cells from murine bone
marrow into seven subsets that correspond to discrete cells (Whitlock and Witte, 1982). As shown in Figure 1B,
AA4.11 cells, but not AA4.12 cells, could proliferate on astages of differentiation (Hardy et al., 1991). The combi-
nation of antibodies against CD45R (B220), CD43 (S7), stromal cell layer. Phenotypic analysis by flow cytometry
(data not shown) revealed that these proliferating cellsCD24 (HSA), and BP-1 allowed for the delineation of
four cell fractions representing the pre-pro-B to early were B2201HSA1, indicating progression to the pro-B
or pre-B cell stage.pre-B cell stages (Fr. A, B, C, and C9 in Figure 1A). We
found that theearliest B2201CD431 B lineage progenitor An obvious question raised by this analysis is whether
the newly delineated population consists predominantlycells (Fr. A in Figure 1A) constituting 1%–1.5% of total
bone marrow cells could be distinguished from more of early B lineage cells or instead is still quite heteroge-
nous. We attempted to address this issue by a singledifferentiated B2201CD431 cells (Fr. B, C, and C9) by
the lack of HSA expression. cell assay, determining expression of a heavy chain
transgene in these two cell subfractions. Expression ofTo define more clearly the earliest stages of commit-
ment of HSC to the B lineage, we used expression of a the transgene is controlled by its own normal heavy
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Figure 2. Phenotypic Analysis of B2201
HSA2 Cells (Fr. A) in Mouse Bone Marrow
Mutually exclusive expression of AA4.1 and
NK1.1 in Fr. A. Four-color immunofluores-
cence analysis with B220, HSA, AA4.1, and
NK1.1 shows that many B2201HSA2 cells
lacking AA4.1 express the NK1.1 cell surface
molecule. The B2201HSA2 gating region for
Fr. A is boxed. Right, AA4.11 Fr. A cells do not
express CD19, whereas most B2201HSA1 B
lineage cells in bone marrow (Fr. B–E) do.
Bone marrow cells were analyzed for B220,
HSA, AA4.1, and CD19 by four-color flow cy-
tometry. Cells in the B2201HSA2 fraction that
bear AA4.1 (corresponding to the cell fraction
boxed in the lower left panel) do not express
detectable levels of CD19. Mature recirculat-
ing B cells (marked Fr. F) also express CD19
(data not shown).
chain enhancer/promoter elements and so should be Fractionating Early Lymphoid Lineage
CD431HSA2AA4.11 Cells Based onfound at an early stage in developing B cells. B2201
Correlated Expression of B220CD431HSA2 cells from Rag-1-deficient mice carrying a
and CD4m transgene were separated into AA4.12 and AA4.11
It has been shown previously that lymphoid progenitorfractions, and the cells were then permeabilized, stained
populations in bone marrow (Fredrickson and Basch,for expression of heavy chain m protein, and analyzed
1989; Chervenak et al., 1993) and thymus (Wu et al.,by flow cytometry (Figure 1C). Fewer than 5% of AA4.12
1991a, 1991b) capable of giving rise to both B and Tshowed m expression, whereas >90% were stained in
cells express low levels of the CD4 molecule. Therefore,the AA4.11 subfraction. Thus, based on ability to tran-
we investigated the expression of CD4 on HSA2AA4.11scribe a heavy chain gene, this subfraction consists of
cells in relation to B220 expression. We found that aa relatively homogenous population of early B lineage
minority of cells were B2201 and that this populationprogenitor cells.
could be divided into two approximately equal parts,The identity of the AA4.12 cells is not established,
each 0.3% of bone marrow, based on the presence orbut staining analysis (Figure 2, left) revealed that many
absence of CD4 (Fr. A1 and A2 in Figure 3). Among theexpress the NK1.1 molecule, a marker of natural killer
larger B2202 population, only a small number of cellscells and a subset of T cells (Koo and Peppard, 1984;
were CD41, although in absolute numbers (0.2% of boneSykes, 1990). We suggest that since AA4.1 expression
marrow) this population (Fr. A0) is similar in size to Fr.marks HSC and early B lineage cells at the D–J rearrang-
A1 and A2. Based on their lack of B220 expression, theseing stage (Fr. B), it is critical to focus on the AA4.11
CD41 cells might be the common lymphoid progenitor
cells in the HSA2 fraction of B2201CD431 cells in bone
population identified by others (Wu et al., 1991a, 1991b).
marrow in analyzing the progression from lymphoid pro-
Thus, fractionation of CD431HSA2AA4.11 cells based
genitor to committed B lineage precursor. on CD4 and B220 expression has allowed us to resolve
Up-regulation of CD19 is considered to be one of the three bone marrow cell subsets, A0, A1, and A2, that may
earliest hallmarks of commitment to the B cell lineage represent the earliest stage of B cell development.
(Krop et al., 1996; Rolink et al., 1996), and so we next
tested this newly identified B2201HSA2AA4.11 early
progenitor population for CD19 surface expression. IgH Germline Transcription Precedes
While developmentally more mature bone marrow B lin- Rag-1/2 Expression in Fr. A1 and A2
eage populations (Fr. B and later) are CD191, the To learn about the extent of B lineage commitment
B2201HSA2AA4.11 cells were CD192 (Figure 2), indicat- within these fractions, we investigated the level of tran-
ing that the AA4.11 subfraction of Fr. A is composed of scription from the germline IgH loci, m0. m0 expression is
one of the earliest indications of B lineage commitmentvery primitive B lineage cells.
Immunity
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Expression of B Lineage–Restricted Genes
in Fractions A0, A1, and A2
To strengthen the assignment of Fr. A1 and A2 cells to
the B lineage, we used semiquantitative reverse tran-
scriptase–polymerase chain reaction (RT–PCR) to mea-
sure the mRNA levels of three B-restricted components
of the pre-B cell receptor complex, l5, Iga (mb-1), and
Igb (B29) (Melchers et al., 1993; Reth, 1993). As shown
in Figure 5A, both l5 and mb-1 were undetectable in
Fr. A0 and A1. Expression of these genes commences
at low levels in Fr. A2, and thereafter increases sharply
in Fr. B, similar to Rag-1/2. More notably, in Fr. A1 and
A2, B29 gene expression reaches approximately 25%
Figure 3. Flow Cytometry of BALB/c Bone Marrow Delineating Early and 50% of the peak levels seen in Fr. B, respectively.
Stages of B Lineage Development
This veryearly detection of B29 not only further supports
Bone marrow cells were stained simultaneously with FL-anti-HSA,
the assignment of Fr. A1 and A2 to the B lineage, butPE-AA4.1, BI-anti-B220 (revealed by TR–avidin), and APC-anti-CD4.
also indicates that Fr. A2 cells are more mature than Fr.The AA4.11 fraction of B2201CD431HSA2 cells (Fr. A) can be subdi-
A1 cells, substantiating our ordering of these fractions.vided into Fr. A1 (0.3% of total bone marrow cells) and A2 (0.3% of
total) based on expression of CD4. Low level expression of CD4,
similar to that in Fr. A1, is also detectable on a portion of AA4.11
Expression of B Lineage TranscriptionB2202HSA2 cells, designated A0 (0.2% of total). Control staining for
Factors in Fractions A0, A1, and A2setting the sort gate with this very dim CD4 expression is also
shown. To define better transcriptional control of early B cell
differentiation, we quantitated the gene expression of
four transcription factors involved in regulating B cell
development, B cell lineage–specific activator protein(Schlissel et al., 1991b; Alessandrini and Desiderio,
(BSAP) (Barberis et al., 1990), E12 and E47 (encoded by1991), reflecting the remodeling of chromatin structure
the E2A gene) (Kadesch, 1992; Bain et al., 1994), and Idto make the heavy chain locus accessible to re-
(inhibitor of DNA binding) (Wilson et al., 1991; Benezraarrangement (Alt et al., 1987). Experiments using Abel-
et al., 1990). RT–PCR analysis revealed that the veryson murine leukemia virus–transformed lymphoid cell
early fraction A0 has a high level of Id expression, anlines representing various stages of B cell development
intermediate level of E47, a relatively low level of E12,have shown that IgH germline transcripts can be de-
and no BSAP expression (Figure 5B). Subsequently, Idtected before or coincident with IgH rearrangement
expression is down-regulated in fraction A1 and remains(Yancopoulos and Alt, 1985; Schatz et al., 1992). These
low in Fr. A2 and B, whereas E12, E47, and BSAP areobservations suggested that germline transcription of
gradually up-regulated in Fr. A1 and A2 before reachingthe IgH loci would be a useful marker for testing the
their highest levels in fraction B. Thus, the up-regulationextent of B lineage commitment in normal precursor cell
of E12, E47, and BSAP gene expression in Fr. A1 andpopulations. We have also measured the levels of Rag-1
A2, which continues into Fr. B, again supports assigningand Rag-2 transcription, since these genes are essential
these fractions to the B lineage, and the sharp down-for IgH rearrangement (Mombaerts et al., 1992; Shinkai
regulation of Id that occurs in Fr. A1 may signal theet al., 1992) and their expression would be expected to
release of Fr. A0 from an uncommitted state, as pre-precede or be coincident with initiation of heavy chain
viously suggested by the pattern of m0 up-regulation.rearrangement.
As illustrated in Figure 4A, IgH germline transcript m0
is initiated upstream of the JH1 gene segment and is Discussion
properly spliced from JH1 to the first Cm exon (Schlissel
et al., 1991b). A0 cells, which do not express B220, show In this study we have used functional criteria as well as
little detectable m0 transcripts or Rag-1/2 expression molecular markers to identify fractions of cells repre-
(see Figures 4B and 4C). However, coincident with B220 senting the earliest stages of B lineage differentiation
expression, m0 is up-regulated sharply in Fr. A1, prior to in mouse bone marrow and in addition have ordered
detection of significant levels of Rag-1/2. A2 cells, which these fractions into a developmental progression. Two
have lost CD4, continue to show high levels of m0 tran- AA4.11 subfractions of B2201HSA2 cells, designated Fr.
scripts, but in addition have initiated Rag-1/2 expres- A1 and A2, constitute the earliest stages of B lineage
sion, which must occur before rearrangement. Finally, development. These fractions have high levels of germ-
m0 transcription decreases sharply in Fr. B when Rag- line m transcripts but very low levels of Rag-1 and Rag-2
1/2 expression reaches maximal levels. This decline of expression, indicative of early B lineage commitment.
m0 expression in Fr. B is likely due to extensive D–J In addition, cells from these fractions can survive and
rearrangement (Hardy et al., 1991) that results in the generate pro- and pre-B cells in short-term stromal-
loss of the transcription start site. These data indicate dependent culture, a characteristic property of B lineage
that Fr. A1 and A2 are committed to the B lineage and precursors (Collins and Dorshkind, 1987; Faust et al.,
that m0 transcription precedes functional recombinase 1993; Hardy et al., 1991). The B lineage nature of these
fractions is furthersupported by their expression of B29,activity in vivo.
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Figure 4. Expression of Rag-1, Rag-2, and m0 Transcripts during Early B Cell Development in Mouse Bone Marrow
(A) Schematic of heavy chain locus and germline m transcript (not to scale) showing location of primers used in PCR assay to detect m0
transcripts, which are initiated upstream of JH1 and spliced from JH1 to the first exon of Cm.
(B) Representative autoradiographs of RT–PCR analysis of Rag-1, Rag-2, and m0 expression in bone marrow Fr. A0–B. Shown are 1–2 hr
exposures of 18 cycles (b-actin) or 22 cycles (Rag-1, Rag-2, and m0) of amplification. Differences in loading result in the apparent decrease
in Rag-2 expression between Fr. A0 and A1. Variation in amount of RNA or cDNA (or both) is normalized to expression of the b-actin
“housekeeping” gene to obtain changes in relative expression (in [C]).
(C) Plot of RT–PCR results for the expression of Rag-1, Rag-2, and m0 in bone marrow Fr. A0–B. Amplitude of message is reported relative to
the maximum value obtained in the analyses. Data from a minimum of three independent determinations are shown. See Experimental
Procedures for further details.
a B cell–specific gene that encodes Igb, one of the CD3- critical decision point in the development of the B cell
lineage. These fractions and the provisional orderinglike immunoglobulin-associated chains important in
transducing signals through the B cell antigen receptor. suggested by changes in gene expression documented
in this study are summarized in Table 1.Finally, the expression on Fr. A1 cells of low levels of
CD4, known to mark more unrestricted progenitor popu- An essential aspect of this analysis is the discrimina-
tion of cells based on expression of the AA4.1 determi-lations (Wu et al., 1991a, 1991b; Chervenak et al., 1993),
demonstrates the very primitive nature of this popula- nant. AA4.1 expression, originally shown to mark early
B lineage cells (McKearn et al., 1985), has been used totion. Thus, we have identified fractions of cells at a
Figure 5. Gene Expression in Successive Stages of Early B Lineage Cells
(A) Plot of RT–PCR analysis of B lineage–specific genes B29 (Igb), mb-1 (Iga), and l5 in bone marrow Fr. A0–B.
(B) Plot of RT–PCR analysis of expression of the B lineage transcription factors Id, BSAP, E12, and E47 in bone marrow Fr. A0–B.
For both sets of graphs, amplitude of message is reported relative to the maximum value obtained in these analyses. See Experimental
Procedures for details.
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light chains, assembled to form the surface IgB cellTable 1. Surface Phenotype and Gene Expression of Bone
Marrow Fractions Characterized in This Report antigen receptor.
AA4.1 also labels cells in bone marrow that lack B220,Bone Marrow Fraction
Surface presumably stem cells and their immediate progeny.
Molecule Fr. A0 Fr. A1 Fr. A2 Fr. B Considering that CD4 expression has been used to dis-
AA4.1 1 1 1 1 criminate a hematopoietic precursor subset in thymus
CD43 1 1 1 1 with the capacity to repopulate both B and T lineage
CD4low 1 1 2 2 cells (Wu et al., 1991a, 1991b), we also isolated and
B220 2 1 1 1 analyzed a B2202 subset of AA4.11 bone marrow that
HSA 2 2 2 1
expresses low levels of CD4. Consistent with their desig-CD19 2 2 2 1
nation as relatively unrestricted progenitor cells, we
Gene found no significant expression of genes associated
m0 2 111 111 2 with B lineage commitment in this subset, which we have
Rag-1/2 2 6 1 111 termed A0. However, this subset is likely to represent the
B29/Igb 2 1 11 111 immediate precursor to Fr. A1, since it expresses similar
mb-1/Iga 2 2 1 111
levels of CD4. The homogeneity and purity of this frac-
l5 2 2 1 111
tion is difficult to assess, since it lacks expression ofId 111 1 1 1
gene markers we investigated here and does not tran-E47 1 1 11 111
E12 6 1 11 111 scribe a heavy chain transgene (data not shown). Never-
BSAP/Pax-5 2 1 11 111 theless, in preliminary experiments, transfer of cells from
this fraction into SCID mice has resulted in prolongedSurface molecules detected by flow cytometry; gene expression
determined by RT–PCR. Number of pluses reflects relative level of generation of large numbers of both B and T cells. Thus
expression. cells with high proliferative potential for reconstituting
lymphoid (and perhaps other) lineages are contained in
this fraction.
delineate stem cells and cells with B progenitor activity Comparison of the B2202 with the B2201 fractions of
in fetal liver (Jordan et al., 1990; Cumano and Paige, these AA4.11 cells raises the issue of the extent of their
1992; Cumano et al., 1992). In bone marrow, AA4.1 is B lineage commitment. Certainly the B2202 subset of
also expressed on some non–B lineage (B2202) cells the AA4.11 fraction should include HSC, as this marker
(Figure 3; unpublished data), presumably immature cells has been used previously to isolate stem cells (Jordan
of other hematopoietic lineages. Its role here is to dis- and Lemischka, 1990; Jordan et al., 1990; Matthews et
criminate B lineage precursor cells from non–B lineage al., 1991). Furthermore, Chervenak et al. (1993) have
cells contaminating the B2201HSA2 fraction that we shown that low level CD4 expression in mouse bone
previously termed Fr. A (Hardy et al., 1991; Li et al., marrow characterizes progenitor cells more differenti-
1993). Rolink et al. (1996) recently noted the presence ated than the long-term reconstituting HSC, but still with
of NK1.11 cells in this fraction and reported that culture multilineage repopulating capacity. Thus, it is likely that
of Fr. A cells with interleukin-2 (IL-2) will expand a popu- A0 is not yet B lineage committed, whereas the potential
lation of non–B lineage cells. In their study, these investi- of A1 and A2 to generate other lineages remains to be
gators focused on the use of CD19 as a more specific tested. Specifically, itwill be interesting to test the malle-
marker of early B lineage cells compared with B220. ability of cells in these fractions by characterizing their
Here, we show that B220 in conjunction with AA4.1 iden- capacity to generate T cells in thymic organ culture. In
tifies a distinctive fraction of precursor cells, poised to summary, our identification and molecular characteriza-
differentiate down theB lineage, yet lacking CD19. Thus, tion of fractions A0, A1, A2, and B provides the basis
CD19 expression does not provide the first tangible evi- for further comparison in functional analysis of lineage
dence of B lineage commitment. restriction, as has been done with AA4.11 fetal liver
We previously referred to the B2201HSA2 fraction (Fr. bipotential B/myeloid progenitors (Cumano and Paige,
A) as pre-pro-B cells when, in fact, Fr. A contained more 1992; Cumano et al., 1992).
than just early B lineage cells, as shown here. With the An important measure of B lineage commitment is the
additional criteria of AA4.1 and CD4 expression, we now expression of lineage-specific genes such as surrogate
believe that Fr. A1 and A2 represent relatively pure popu- light chain components l5/Vpre-B (Melchers etal., 1993)
lations of pre-pro-B stages because they are precursors and the immunoglobulin-associated molecules Iga/Igb
to the pro-B (and later) stage cells. The designation of encoded by the mb-1/B29 genes (Reth, 1993). Previous
cells in these subfractions as early B lineage is based studies examining expression of these genes in E2A
on their capacity to express a heavy chain transgene, knockout mice, in which B cell development is blocked
a single cell, rather than bulk population, analysis. Cells in the pro-B stage (Bain et al., 1994), showed that while
in Fr. B and C contain extensive D–J rearrangement, but levels of l5 and mb-1 transcripts were significantly re-
lack functional heavy chain expression; we call them duced, B29 expression was only modestly decreased.
pro-B cells (progenitors of B cells) since they can expand This led to the suggestion that the onset of B29 expres-
significantly and generate mature B cells upon transfer sion is a very early event during B cell differentiation,
to SCID mice (Hardy and Hayakawa, 1991). Fr. C9 and preceding both l5 and mb-1. Our detection of a signifi-
D are composed of pre-B cells that express m heavy cant level of B29 transcript in Fr. A1, as well as in A2, is
chains prior to light chain. Finally, Fr. E and F consist consistent with this prediction and also confirms the B
lineage nature of these fractions. Recently, Gong andof B cells expressing both immunoglobulin heavy and
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Nussenzweig (1996) reported that targeted inactivation Rosnet et al., 1991), and IL-7 (Namen et al., 1988; Lee
et al., 1989), by directly studying the effects of theseof Igb resulted in a block at the B2201CD431 stage of
B cell development. This block in development and their molecules on the three newly defined fractions. It should
also be possible to test directly the roles of transcriptionobservation that V to D–J rearrangement was severely
decreased, whereas D–J rearrangement was unaf- factors in the regulation of early events in commitment
to the B lineage by analysis of these fractions in gene-fected, supports a role for Igb very early in B cell devel-
opment, possibly mediating signals of a pro-B cell re- targeted and transgenic mice.
ceptor consisting of surrogate light chain complexed
Experimental Procedureswith a surrogate heavy chain molecule (Karasuyama et
al., 1993, 1994).
Mice and Cell PreparationThe generation of lineage-committed cells from pluri-
Bone marrow was obtained from 2- to 4-month-old female BALB/
potential stem cells is tightly controlled by a set of tran- cAnN mice or B6 mice bred in our animal facility. A single cell
scription factors (Shivdasani and Orkin, 1996), of which suspension of bone marrow (femur and tibia) was prepared by in-
jecting staining medium (deficient RPMI; IrvineScientific, Santa Ana,the helix-loop-helix proteins E12 and E47 (Kadesch,
CA) containing 10 mM HEPES, 3% FCS, and 0.1% NaN3 into the1992; Bain et al., 1994) and Id (Wilson et al., 1991; Bene-
bone to flush out cells, followed by gentle mixing with a 1 ml syringe.zra et al., 1990) play critical roles in B lineage develop-
Cells were treated with 0.165 M NH4Cl to lyse erythrocytes.ment. Although E47 polypeptides are present ubiqui-
tously, the DNA-binding homodimer of E47 is expressed Staining, Flow Cytometry Analysis, and Cell Sorting
specifically in Bcells (Benezra, 1994; Shenand Kadesch, The fluorescent rat monoclonal antibodies used in these experi-
ments were as follows: for Fr. A0–A2, fluorescein (FL)-30F1 (anti-1995). Furthermore, mice with homozygous deletions of
CD24/HSA), phycoerythrin (PE)-AA4.1 (anti-AA4.1), biotin (BI)-6B2the E2A gene lack mature B cells and have reduced
(anti-CD45R/B220), PE-CD19 (anti-CD19), and allophycocyaninnumbers of bone marrow B2201CD431 cells, suggesting
(APC)-GK1.5 (anti-CD4); for Fr. A–C, FL-S7 (anti-CD43), PE-BP-1an early block in B cell development (Bain et al., 1994;
(anti-BP-1), BI-30F1, and APC-6B2. Monoclonal antibodies were
Zhuang et al., 1994). These remaining B2201CD431 cells purified and labeled in our laboratory, as previously described
likely correspond to our fraction A1 and A2, since our (Hardy, 1986). Cells were incubated with the appropriate combina-
tions of the above antibodies in staining medium on ice for 15 min,observations, as well as those of Schlissel et al. (1991a),
washed three times with staining medium, then incubated a furtherimplicate E12 and E47 in the progression of B cell differ-
15 min with Texas red (TR)–avidin to reveal the BI reagent, andentiation from the committed progenitor stage (Fr. A1
finally washed twice with staining medium. Flow cytometry analysisand A2) to the early pro-B cell stage (Fr. B). Id can form and sorting was carried out using a dual laser/dye laser flow cyto-
heterodimers with E12 or E47, thereby inhibiting their meter (FACStar Plus, Becton Dickinson Immunocytometry System,
DNA binding ability (Benezra et al., 1990), and down- San Jose, CA) equipped with appropriate filters for four-color immu-
nofluorescence. Samples were held on ice during sorting. Reanaly-regulation of Id is associated with differentiation in the
sis of sorted fractions consistently showed purities in excess ofmyeloid lineage (Kreider et al., 1992). Furthermore, con-
95%. Selected populations were sorted directly into microcentrifugestitutiveexpression of Id inmice carrying an Id transgene
tubes containing guanidinium thiocyanate lysis buffer for RNA prep-under the control of a mb-1 promoter and IgH enhancer
aration (Li et al., 1993).
(Sun, 1994) results in impaired B cell development at For detection of cytoplasmic expression of a human m transgene,
the pro-B cell stage. Thus, we suggest that the sharp AA4.12 and AA4.11 subsets of CD45R (B220)1CD431HSA2 cells
from Tg1Rag-12 bone marrow (Spanopoulou et al., 1994) weredown-regulation of Id expression in Fr. A1 may result in
sorted into RPMI 1640 supplemented with 10% FCS and pelleted.the release of E2A proteins from Id binding, allowing for
The cells were then fixed and permeabilized using the reagents andB lineage differentiation through formation of active E2A
protocol supplied with the Fix and Perm kit from Caltag Laboratorieshomodimers. Finally, the B cell–specific transcription
(San Francisco, CA). A PE-labeled goat anti–human m heavy chain
factor BSAP, encoded by the Pax5 gene, is a member (Southern Biotechnology Associates, Inc., Birmingham, AL) was
of the family of paired-box genes (Adams et al., 1992), used to assess transgene expression. PE-labeled irrelevant control
reagents were used to establish backgrounds. Subsequent flowand binding sites for this molecule have been identified
cytometry analysis was performed on a FACScan (Becton Dick-in the promoters of the B lineage–restricted genes CD19
inson).(Kozmik et al., 1992) and VpreB (Okabe et al., 1992) and
in several regulatory regions of the IgH locus (Singh and
Cell Culture
Birshtein, 1993; Waters et al., 1989; Xu et al., 1992). Its The cell growth assay was performed as described previously
importance in B lineage development has been directly (Hardy et al., 1991). In brief, 104 cells were sorted onto the FLST2
demonstrated in BSAP gene–targeted mice that show stromal cell layer and cultured in standard medium (RPMI 1640
supplemented with 5 3 1025 M 2-ME, 5% FCS) containing 100 U/mlan arrest of B cell differentiation at the pro-B cell stage
rIL-7 (provided by Dr. S. Gillis; Immunex Corp., Seattle, WA) in a(Urbanek et al., 1994). Consistent with this observation
humidified 5% CO2 incubator at 378C for 7 days. Cells recoveredis our finding that BSAP expression initiates in Fr. A1 from culture were stained with antibodies to CD45R (B220), IgM,
and rises through Fr. A2 and B. and HSA and counted on a flow cytometer.
In summary, our identification of the earliest stages of
B lineage differentiation provide a useful tool for further RT–PCR Assay
Cells (105) were sorted into microcentrifuge tubes containing RNAstudy of the process of commitment and should aid in
lysis buffer (6 M guanidine thiocyanate, 0.67% Na N-lauroylsarcos-defining the molecular triggers that govern B cell lym-
ine, 33 mM Na citrate, and 133 mM 2-mercaptoethanol). The cellphopoiesis and homeostasis. For example, it should be
lysate was mixed with 1/10 vol of 2 M sodium acetate (pH 4.0), 1
possible to determine rigorously the influence on early vol of H2O-saturated phenol, and 2/10 vol of chloroform:isoamyl
B cell differentiation of environmental factors in the bone alcohol (49:1), vortexed, and incubated on ice for 15 min. The lysate
marrow, such as kit ligand (Williams et al., 1990; Flana- was then centrifuged at 10,000 rpm at 48C for 15 min, and the
upper aqueous phase was collected. We added 20 mg of glycogengan and Leder, 1990), flk2/flt 3 (Matthews et al., 1991;
Immunity
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(Boehringer Mannheim Biochemicals, Indianapolis, IN) as a carrier, homodimers and is required for DNA binding at physiological tem-
peratures. Cell 79, 1057–1067.and RNA was precipitated by adding 1 vol of isopropanol. The RNA
pellets were washed once with 70% ethanol and resuspended in 8 Benezra, R., Davis, R.L., Lockshon, D., Turner, D.L., and Weintraub,
ml of DEPC-treated H2O. To eliminate any trace of DNA contamina- H. (1990). The protein Id: a negative regulator of helix-loop-helix
tion, the RNA samples were incubated with 1 ml (1 U/ml) of DNase DNA-binding proteins. Cell 61, 49–59.
I and 1 ml of 103 DNase I Buffer (Life Technologies, Grand Island, Chervenak, R., Dempsey, D., Soloff, R., Wolcott, R.M., and Jennings,
NY) at room temperature for 15 min. DNase I was inactivated in the S.R. (1993). The expression of CD4 by T cell precursors resident in
RNA samples by the addition of 1 ml of 25 mM EDTA and heating both the thymus and the bone marrow. J. Immunol. 151, 4486–4493.
at 658C for 10 min.After bringing the total volume of the RNAsamples
Collins, L.S., and Dorshkind, K. (1987). A stromal cell line from my-to 20 ml with H2O, 4 ml of each sample was used for first strand
eloid long-term bone marrow cultures can support myelopoiesiscDNA synthesis using random hexamers (Pharmacia, Piscataway,
and B-lymphopoiesis. J. Immunol. 138, 1082–1087.NJ) and Moloney murine leukemia virus reverse transcriptase (Life
Cumano, A., and Paige, C. (1992). Enrichment and characterizationTechnologies) as previously described (Li et al., 1993).
of uncommitted B-cell precursors from fetal liver at day 12 of gesta-cDNA was amplified by PCR using gene-specific primers. Primers
tion. EMBO J. 11, 593–601.for Rag-1, Rag-2, l5, mb-1, and b-actin have been described pre-
viously (Li et al., 1993); the other primers used were as follows: m0, Cumano, A., Paige, C.J., Iscove, N.N., and Brady, G. (1992). Bipoten-
59-AACATCTGAGTTTCTGAGGCTTGG, 59-TCATCTGAACCTTCAAG tial precursors of B cells and macrophages in murine fetal liver.
GATGCTC; Id, 59-TCCAACTTCTTGTTCTCTTCCC, 59-CACAAGAT Nature 356, 612–615.
GCGATCGTCG; BSAP, 59-TCCTCGGACCATCAGGACAG, 59-CCTG Ehlich, A., Schaal, S., Gu, H., Kitamaru, D., Muller, W., and Rajewsky,
TTGATGGAGCTGACGC; E12, 59-CGCACTGACCACGAGCTTCAC, K. (1993). Immunoglobulin heavy and light chain genes rearrange
59-GGTCGTCCTCGTCCTCGTCTG; E47, 59-CGCACTGACCACGAG independently at early stages of B cell development. Cell 72,
CTTCAC, 59-TCCAGGGACAGCACCTCATCTG. B29, 59-CTGGTGCT 695–704.
GTCTTCCATGC, 59-GATGAGGAGGGTCTGGATCA. PCR, blotting,
Faust, E.A., Saffran, D.C., Toksoz, D., Williams, D.A., and Witte,and hybridization were performed as previously described (Li et al.,
O.N. (1993). Distinctive growth requirements and gene expression1993). In brief, aliquots were withdrawn at 18 and 22 (b-actin), 22
patterns distinguish progenitor B cells from pre-B cells. J. Exp. Med.and 26 (Rag-1, Rag-2, m0, l5, B29, mb-1, BSAP, E12, and E47), or
177, 915–923.26 and 30 (Id) cycles for separate analysis to ensure that amplifica-
Flanagan, J.G., and Leder, P. (1990). The kit ligand: a cell surfacetion was within the linear range. b-Actin served as a control for
molecule altered in steel mutant fibroblasts. Cell 63, 185–194.efficiency of RNA isolation and to verify that equal amounts of cDNA
were added to each PCR reaction. One fifth of the PCR samples Fredrickson, G.G., and Basch, R.S. (1989). L3T4 antigen expression
were then separated by 1.5% agarose gel electrophoresis and blot- by hemopoietic precursor cells. J. Exp. Med. 169, 1473–1478.
ted onto Hybond N membrane (Amersham, Arlington Heights, IL). Gong, S., and Nussenzweig, M.C. (1996). Regulation of an early
Filters were UV crossed-linked, prehybridized for 1–3 hr, hybridized developmental checkpoint in the B cell pathway by Igb. Science
overnight (at 428C) with riboprobes prepared from the PCRproducts, 272, 411–414.
and then washed before imaging on X-ray film. Quantitation of signal
Hardy, R.R. (1986). Purification and coupling of fluorescent proteinswas performed using a two-dimensional proportional scintillation
for use in flow cytometry. In Handbook of Experimental Immunologydetector (Ambis, San Diego, CA). Radioactivity in individual bands
(Oxford: Blackwell Scientific Publications, Ltd.), pp. 31.31–31.12.representing each PCR product was measured (counts per minute)
Hardy, R.R., and Hayakawa, K. (1991). A developmental switch inand normalized using the b-actin signal for each sample.
B lymphopoiesis. Proc. Natl. Acad. Sci. USA 88, 11550–11554.
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